..and no, we were not told that the reason the EMA knocked VG back was because there were concerns as to its efficacy. We were told it was knocked back because the EMA considered that it was not a device and it had been entered under the wrong category.
Ann: Chairman's Address to AGM and Shareholder Presentation, page-4
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
